STOCK TITAN

CalciMedica: StemPoint reports 9.99% beneficial stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

CalciMedica, Inc. (CALC) common stock is reported as beneficially owned by StemPoint Capital LP, StemPoint Capital Management GP LLC and Michelle Ross; each reporting person may be deemed to beneficially own 730,223 shares, or 9.99%. The reported amount comprises 248,972 common shares, 248,972 shares underlying Series A Warrants and 232,279 shares underlying Series B Warrants. The warrants are subject to a 9.99% beneficial ownership limitation.

The percentage calculation uses 6,828,292 common shares issued and outstanding as of August 5, 2026, adjusted for the 1-for-5 reverse stock split effective August 27, 2026, and adds the Series A and Series B warrant shares included in the reported amount. The cover-page percentages are rounded down to 9.9%.

Beneficially owned shares 730,223 shares Each reporting person may be deemed to beneficially own this amount.
Common shares 248,972 shares Included in the reported beneficial ownership amount.
Series A Warrant shares 248,972 shares Shares underlying warrants included in the reported beneficial ownership amount.
Series B Warrant shares 232,279 shares Shares underlying warrants included in the reported beneficial ownership amount.
Beneficial ownership percentage 9.99% Each reporting person may be deemed to beneficially own this percentage.
Common shares issued and outstanding 6,828,292 shares As of August 5, 2026; adjusted for the 1-for-5 reverse stock split effective August 27, 2026.
Excluded Series B Warrant shares 16,693 shares Excluded from the beneficial ownership calculation; subject to the Beneficial Ownership Limitation.
Beneficial Ownership Limitation financial
"subject to a beneficial ownership limitation of 9.99%"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
Series A Warrants financial
"shares of Common Stock underlying Series A Warrants"
Series A warrants are financial tools that give the holder the right to buy shares of a company at a specific price within a certain period. They are often issued alongside investments to provide additional potential profit if the company's value increases. For investors, they can offer a chance to benefit from future growth without committing immediate capital to buying shares.
Series B Warrants financial
"shares of Common Stock underlying Series B Warrants"
Series B warrants are contracts issued alongside a company's Series B financing that give the holder the right to buy a set number of shares at a fixed price within a specified time. For investors, they matter because they can provide leveraged upside if the company grows, or they can dilute existing shareholders when exercised—like a coupon promising a future share at a known price that can add value or change ownership stakes.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CALC shares do the reporting persons beneficially own?

Each reporting person may be deemed to beneficially own 730,223 shares of CALC common stock, representing 9.99%. The reported amount comprises 248,972 common shares, 248,972 shares underlying Series A Warrants and 232,279 shares underlying Series B Warrants.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





38942Q301

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G




Comment for Type of Reporting Person: StemPoint Capital Management GP LLC is a limited liability company.


SCHEDULE 13G





SCHEDULE 13G



StemPoint Capital LP
Signature:/s/ Sean C. Tan
Name/Title:Sean C. Tan, Authorized Signatory
Date:11/16/2026
StemPoint Capital Management GP LLC
Signature:/s/ Sean C. Tan
Name/Title:Sean C. Tan, Authorized Signatory
Date:11/16/2026
Michelle Ross
Signature:/s/ Michelle Ross
Name/Title:Michelle Ross
Date:11/16/2026
Exhibit Information

JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)

Keep reading